Search Results 21-30 of 16340 for Obesity%2FOverweight%20Treatment
Metabolic syndrome is closely linked to overweight or obesity and inactivity. It's also linked to a condition called insulin resistance. Normally, your ...
The purpose of this study is to prospectively evaluate the safety and effectiveness of standard of care, individualized, comprehensive weight loss interventions ...
Understand why weight gain is linked to insulin treatment, and find out how to dodge those extra pounds while still managing your blood sugar.
The American Academy of Pediatrics (AAP) released updated guidelines on the evaluation and treatment of children with obesity, recommending a new ...
The purpose of this study is to evaluate a treatment for obesity. Participation eligibility. Participant eligibility includes age, gender, type and stage of ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study ...
Jensen. Even looking at fat cells gives you that idea. Their most striking feature is a giant reservoir containing a triglyceride (similar to cooking oil) with ...
Lorcaserin was approved by the FDA on June 2012 for weight management in people with a BMI of > 27 kg/m2 (overweight) when accompanied by a weigh-related ...
... overweight or obese and 17 percent of children are obese in the United States. ... management of obesity; we need to individualize the obesity treatment. It is ...
There is also a drug that has a higher dose of liraglutide (Saxenda) that's approved for the treatment of obesity in people who don't have diabetes. If you ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.